Depakote ERdivalproex

45,703 adverse event reports submitted to the FDA (1998–2026)

This data reflects voluntary reports submitted to the FDA's Adverse Event Monitoring System (AEMS), formerly the FDA Adverse Event Reporting System (FAERS). A report does not mean the medication caused the event. Data may be incomplete or contain errors. Learn more about AEMS. New to this data? Read our guide on how to interpret FDA adverse event reports →
New to FDA adverse event data? Here's how to read these reports →

Top Reported Adverse Events

The most frequently reported events in association with Depakote ER in the FAERS database. These are events reported by patients taking this medication, not necessarily caused by it. A single report may include multiple events.

Show these terms with plain-language definitions

Tap any term below for a plain-language definition.

Browse the full glossary →

Ranked by frequency of reports, not severity. The most-reported event is not necessarily the most dangerous or the most common in patients taking this drug.

Who Is Reporting

Demographics of patients in FAERS reports that included this information. Not all reports include patient demographics.

By Sex

View reporter sex data as a table
Depakote ER adverse event reports by reporter sex
SexReports
Female21,404
Male19,804
Unknown310

By Age Group

View age group data as a table
Depakote ER adverse event reports by reporter age group
Age groupReports
0-172,773
18-345,168
35-496,463
50-647,278
65-742,583
75+1,453

This shows who filed reports, reflecting who takes this drug and who tends to report, not who is at greatest risk.

Reported Outcomes

Outcomes recorded in FAERS reports that included Depakote ER. A single report may involve multiple reactions, each with a different outcome. These categories are defined by FDA reporting guidelines, not by PillSignal.

View outcome data as a table
Depakote ER adverse event reports by reported outcome
OutcomeReports
Other Serious19,401
Non-Serious15,109
Hospitalization14,885
Death2,531
Life-Threatening1,696
Disability1,354

Serious outcomes are far more likely to be reported than mild ones, so this overstates how often outcomes are serious. A recorded death does not mean the drug caused it.

Number of FAERS reports received per quarter for Depakote ER. Changes in volume may reflect shifts in prescribing rates, media attention, or reporting behavior, not changes in the medication's safety profile.

View report trend as a table
Depakote ER adverse event reports by year
YearReports
19981
20011
20021
20032
20041,204
20051,348
20061,266
20071,290
20081,683
20092,925
20102,530
20112,325
20122,289
20131,971
20142,047
20152,701
20162,840
20172,368
20182,214
20192,254
20202,011
20212,121
20222,174
20231,896
20241,863
20251,940
2026 (partial)438

The steep increase around 2004 reflects the FDA's move to electronic submission, not a change in this drug's safety. Trends track reporting volume, not risk.

Medications commonly reported with Depakote ER

In FDA adverse event reports that mention Depakote ER, these medications appeared most often in the same report.

This reflects co-occurrence in submitted reports, not evidence of drug interaction or combined risk. People often report several medications taken for the same condition or for unrelated reasons. Talk to a doctor or pharmacist about your specific medications.

Other medications with similar adverse event profiles in FDA FAERS reports.

Data Source

This data is sourced from the FDA's Adverse Event Monitoring System (AEMS), formerly FAERS, via the OpenFDA API. PillSignal is not affiliated with the FDA.

View this data on the FDA website →

Data last updated: June 2026